- DocumentCase Discussion 1încărcat deDinar Danan Sukmawati
- DocumentKTI NUR BAB IV baruîncărcat deDinar Danan Sukmawati
- DocumentSepsis and Shock Sepsisîncărcat deDinar Danan Sukmawati
- Document1475-2875-10-278încărcat deDinar Danan Sukmawati
- DocumentPedoman Penatalaksana Kasus Malaria Di Indonesiaîncărcat deDinar Danan Sukmawati
- DocumentStok Ranap Sep -Ok 20 Lokasi Depo Ranapîncărcat deDinar Danan Sukmawati
- DocumentFormularium Spesialistik Ilmu Penyakit Dalamîncărcat deDinar Danan Sukmawati
- Document1013-1920-1-SMîncărcat deDinar Danan Sukmawati
- DocumentCheck List Supervisi Apotekerîncărcat deDinar Danan Sukmawati
- DocumenthighAlert2018-Acute-Final (2).pdfîncărcat deDinar Danan Sukmawati
- DocumentCHECK LIST SUPERVISI APOTEKER.pdfîncărcat deDinar Danan Sukmawati
- DocumentDaftar Regulasi Snars 1încărcat deDinar Danan Sukmawati
- Documentinsulin pharmacology therapeutic regimen and priciple of intensive insulin theraphy 2încărcat deDinar Danan Sukmawati
- DocumentEfficacy and Safety of Combination Antiplatelet Therapiesin Patients With Symptomatic IntracranialAtherosclerotic Stenosis.pdfîncărcat deDinar Danan Sukmawati
- Document01-Update Standar (Dra Arofa Idha MFarm Klin Apt).pdfîncărcat deDinar Danan Sukmawati
- DocumentPrevention of Gastrointestinal Bleeding in PatientsReceiving Direct Oral Anticoagulantsîncărcat deDinar Danan Sukmawati
- DocumentEvaluation of a Potential Clinical Interaction betweenCeftriaxone and Calcium.pdfîncărcat deDinar Danan Sukmawati
- DocumentPERANAN APOTEKER PADA TERAPI CAIRAN DAN ELEKTROLIT.pdfîncărcat deDinar Danan Sukmawati
- DocumentParenteral NutritionFormulation, Monitoring,and Complicationsîncărcat deDinar Danan Sukmawati
- DocumentMeds That Should Not Be Crushedîncărcat deDinar Danan Sukmawati
- DocumentExpert position paper on the use of proton pumpinhibitors in patients with cardiovascular diseaseand antithrombotic therapyîncărcat deDinar Danan Sukmawati
- DocumentPharmacology of Proton Pump Inhibitors.pdfîncărcat deDinar Danan Sukmawati